Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends & Global Forecasts to 2021

Pen needle market offers powerful modalities for molecular imaging in clinical diagnostics and preclinical research in various therapeutic areas. The global pen needles market is expected to reach USD 2.81 Billion by 2021 from an estimated USD 1.65 Billion in 2016, growing at a CAGR of 11.2% during the forecast period. Favorable reimbursement environment and government support in selected countries, advantages of insulin pens over syringes and vials, technological advancements, growing diabetic population, and conferences, meetings, and congresses to create pen needle awareness are expected to propel the growth of this market.

Objectives of the Study

• To define and measure the global pen needles market on the basis of type, length, therapy, mode of purchase, and region
• To identify key micromarkets1 and their drivers within the global pen needles market, which are expected to show impressive growth opportunities in the coming years
• To identify market trends and opportunities for stakeholders in the market
• To strategically analyze the market structure and profile the key players of the global pen needles market and comprehensively analyze their core competencies2
• To track and analyze competitive developments such as partnerships, agreements, and collaborations; expansions; acquisitions; and new product launches

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global pen needle market and estimate the size of various other dependent submarkets. Various secondary sources such as directories, industry journals, databases such as Hoover’s, Bloomberg Business, Factiva, and Avention, and annual reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

To know about the assumptions considered for the study, download the pdf brochure

The major companies in this market include Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), B. Braun Melsungen AG (Germany), HTL-STREFA S.A. (Poland), Terumo Corporation (Japan), Artsana S.p.a (Italy), Owen Mumford Ltd. (U.K.), Allison Medical, Inc. (U.S.), and UltiMed, Inc. (U.S.).

Target Audience:

• Manufacturing companies of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies
• Suppliers and distributors of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies
• Research institutes and academic centers
• Pharmaceutical and biopharmaceutical companies
• Biotechnology companies
• Authorities framing reimbursement policies for pen needles
• Business research and consulting service providers
• Venture capitalists

Scope of the Report

The research report categorizes the global pen needles market into the following segments and subsegments:

Pen Needles Market, by Type

• Standard Pen Needles
• Safety Pen Needles

Pen Needles Market, by Needle lenght

• 4MM
• 5MM
• 6MM
• 8MM
• 10MM
• 12MM

Pen Needles Market, by Therapy

• Insulin
• GLP-1
• Growth Hormones

Pen Needles Market, by Mode of Purchase

• Retail
• Non-Retail

Pen Needles Market, by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia
  • Japan
  • China
  • India
  • Rest of Asia
• Rest of the World (RoW)
  • Latin America
  • Pacific Countries
  • Middle East & Africa

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Competitive Intensity

• Detailed competitive intensity for additional market players (Maximum for one player can be given)

Company Information

• Detailed analysis and profiling of additional market players (up to 3)

Table of Contents

1 Introduction (Page No. - 17)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 20)
    2.1 Research Methodology Steps
    2.2 Secondary and Primary Research Methodology
           2.2.1 Secondary Research
           2.2.2 Primary Research
                    2.2.2.1 Key Data From Primary Sources
                    2.2.2.2 Key Insights From Primary Sources
                    2.2.2.3 Key Industry Insights
    2.3 Market Size Estimation Methodology
    2.4 Research Design
    2.5 Market Data Validation and Triangulation
    2.6 Assumptions for the Study

3 Executive Summary (Page No. - 30)
    3.1 Introduction
    3.2 Current Scenario
    3.3 Future Outlook
    3.4 Conclusion

4 Premium Insights (Page No. - 36)
    4.1 Market Overview
    4.2 Geographic Analysis: Market, By Length
    4.3 Market, By Type
    4.4 Market, By Length
    4.5 Market, By Mode of Purchase
    4.6 Geographic Snapshot: Market

5 Market Overview (Page No. - 40)
    5.1 Introduction
    5.2 Market Segmentation
    5.3 Market Dynamics
           5.3.1 Drivers
                    5.3.1.1 Favorable Reimbursement Environment and Government Support in Selected Countries
                    5.3.1.2 Advantages of Insulin Pens Over Syringes and Vials
                    5.3.1.3 Technological Advancements
                    5.3.1.4 Growing Diabetic Population
                    5.3.1.5 Conferences, Meetings, and Congresses to Create Pen Needle Awareness
           5.3.2 Restraints
                    5.3.2.1 Poor Reimbursement Structure in Developing Countries
                    5.3.2.2 Needle Anxiety
                    5.3.2.3 Alternative Drug Delivery Methods
                               5.3.2.3.1 Oral Diabetic Agents and Oral Insulin
                               5.3.2.3.2 Inhalable Insulin
                               5.3.2.3.3 Nanotechnology to Aid in Transdermal and Inhalational Route of Administering Proteins and Peptides
                    5.3.2.4 Severe Shortage of Endocrinologists in the U.S.
                    5.3.2.5 Reuse of Pen Needles
           5.3.3 Opportunities
                    5.3.3.1 Safety Needles
                    5.3.3.2 GLP-1 Analogues
           5.3.4 Challenges
                    5.3.4.1 Minimizing the Reuse of Standard Pen Needles
                    5.3.4.2 Resistance Against Switching From Conventional Devices to Advanced Devices

6 Industry Insights (Page No. - 52)
    6.1 Introduction
    6.2 Porter’s Five Forces Analysis
           6.2.1 Threat of New Entrants
           6.2.2 Bargaining Power of Suppliers
           6.2.3 Bargaining Power of Buyers
           6.2.4 Segment Rivalry
           6.2.5 Threat of Substitutes
    6.3 Competitive Intensity
           6.3.1 Evaluation Parameters
           6.3.2 Scoring Methodology
           6.3.3 Competitive Intensity Score, By Company
                    6.3.3.1 Competitive Intensity Score for BD
                    6.3.3.2 Competitive Intensity Score for Novo Nordisk
                    6.3.3.3 Competitive Intensity Score for Ypsomed
           6.3.4 Competitive Intensity Mapping of BD, Novo Nordisk, and Ypsomed
           6.3.5 Comparison of Evaluation Parameters, By Company
                    6.3.5.1 Pricing
                    6.3.5.2 Product Portfolio
                    6.3.5.3 Product Launches/Technological Advancements
                    6.3.5.4 Production Capacity (2015)
                    6.3.5.5 Geographical Presence
                    6.3.5.6 Promotional/Marketing Activities
                    6.3.5.7 Sponsorships/Donations/Education/Awareness Campaigns
                    6.3.5.8 M&As, Partnerships, Collaborations, Agreements, and Expansions
                    6.3.5.9 Years of Experience
                    6.3.5.10 Certifications/Accreditations/Awards

7 Pen Needles Market, By Type (Page No. - 72)
    7.1 Introduction
    7.2 Standard Pen Needles
    7.3 Safety Pen Needles

8 Pen Needles Market, By Needle Length (Page No. - 79)
    8.1 Introduction
    8.2 4mm
    8.3 5mm
    8.4 6mm
    8.5 8mm
    8.6 10mm
    8.7 12mm

9 Pen Needles Market, By Therapy (Page No. - 85)
    9.1 Introduction
    9.2 Insulin
    9.3 GLP-1
    9.4 Growth Hormones

10 Pen Needles Market, By Mode of Purchase (Page No. - 91)
     10.1 Introduction
     10.2 Retail
     10.3 Non-Retail

11 Pen Needles Market, By Region (Page No. - 95)
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
                        11.2.1.1 Growing Diabetes Prevalence and Favorable Reimbursement Scenario for Pen Needles
                        11.2.1.2 Federal Initiatives to Stimulate the U.S. Pen Needles Market
                        11.2.1.3 Focus of Leading Players on Increasing Market Penetration in the U.S.
                        11.2.1.4 Improvements in Pen Needle Technologies to Eliminate Needlestick Injuries
                        11.2.1.5 Low Penetration of Pen Injectors in the U.S. as Compared to Europe
             11.2.2 Canada
                        11.2.2.1 High Diabetes Prevalence
                        11.2.2.2 Regulations for the Use of Safety-Engineered Needles
                        11.2.2.3 Government Support for Pen Needles in Alberta
     11.3 Europe
             11.3.1 Germany
                        11.3.1.1 Regulatory Framework to Minimize Needlestick Injuries & Boost Use of Safety-Engineered Devices
                        11.3.1.2 High Diabetes Prevalence and Reimbursement for Pen Needles
             11.3.2 U.K.
                        11.3.2.1 Activities to Pool Funds for Diabetes Care & Research
             11.3.3 France
                        11.3.3.1 Conferences and Exhibitions to Increase Exposure for Pen Needles Players in French Market
                        11.3.3.2 Higher Insurance Coverage and Increase in Aging Population and Affordability
             11.3.4 Italy
                        11.3.4.1 Wide Regional Variations in Terms of Benefits and Coverage to Slow Growth in Italy
                        11.3.4.2 Awareness Campaigns for Diabetes in Italy to Propel the Market Growth
             11.3.5 Spain
                        11.3.5.1 Large Pool of Diabetic Population, Regulations Mandating the Use of Safety Pen Needles
             11.3.6 Rest of Europe
                        11.3.6.1 High Diabetes Prevalence in Russia, Poland, Romania, and Ukraine
     11.4 Asia
             11.4.1 Japan
                        11.4.1.1 High Adoption of Insulin Pens and Approval of Injectable Insulin
             11.4.2 China
                        11.4.2.1 Growing Presence of Global and Local Players in China
                        11.4.2.2 High Diabetes Incidence and Adoption of Insulin Pens
                        11.4.2.3 High Reuse Rate & Lack of Reimbursement to Limit Market Growth
             11.4.3 India
                        11.4.3.1 Growing Presence of Global Players in India
                        11.4.3.2 Low Pen Needle Penetration, Lack of Awareness to Restrain Market Growth
             11.4.4 Rest of Asia
                        11.4.4.1 Vietnam, A Potential Market for Pen Needles
                        11.4.4.2 Increase in Pen Needles Likely in Singapore & Malaysia
     11.5 Rest of the World (RoW)
             11.5.1 Latin America
                        11.5.1.1 Increasing Diabetic Population and Rising Awareness on Diabetes in Brazil
             11.5.2 Pacific Countries
                        11.5.2.1 Amendments in Ndss to Increase Access to Diabetic Products in Australia
                        11.5.2.2 Favorable Reimbursement Scenario and Presence of Charity Organizations in New Zealand
             11.5.3 Middle East & Africa
                        11.5.3.1 Presence of Local & International Pen Needle Manufacturers and Rising Awareness on Pen Needles to Bolster the Market
                        11.5.3.2 Increasing Diabetic Population, Rising Awareness on Diabetes

12 Pen Needle Distributor List (Page No. - 141)

13 Competitive Landscape (Page No. - 149)
     13.1 Overview
     13.2 Market Share Analysis
             13.2.1 Introduction
             13.2.2 Becton, Dickinson & Co.
             13.2.3 Novo Nordisk A/S
             13.2.4 Ypsomed Holding AG
             13.2.5 Others
     13.3 Competitive Situation and Trends
             13.3.1 Marketing and Promotion
             13.3.2 Expansion
             13.3.3 Product Launch
             13.3.4 Others

14 Company Profiles (Page No. - 158)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     14.1 Introduction
     14.2 Becton, Dickinson and Company
     14.3 Novo Nordisk A/S
     14.4 Ypsomed Holding AG
     14.5 Owen Mumford, Ltd.
     14.6 HTL-Strefa S.A.
     14.7 B. Braun Melsungen
     14.8 Terumo Corporation
     14.9 Ultimed, Inc. (LDI, Ltd.)
     14.10 Allison Medical, Inc.
     14.11 Artsana S.P.A.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

15 Appendix (Page No. - 175)
     15.1 Discussion Guide
     15.2 Company Developments (2013-2016)
     15.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     15.4 Introducing RT: Real-Time Market Intelligence
     15.5 Available Customizations
     15.6 Related Reports

List of Tables (102 Tables)

Table 1 10 Countries/Territories With the Highest Number of Diabetics (20–79 Years), 2015 & 2040
Table 2 Favorable Reimbursement Environment in North America & Europe and Growing Diabetic Population to Drive the Growth of the Global Pen Needles Market
Table 3 Poor Reimbursement Structure in Developing Countries is Restraining the Growth of the Market
Table 4 Safety Needles to Offer Significant Growth Opportunities in the Market
Table 5 Minimizing the Reuse of Pen Needles is A Major Market Challenge
Table 6 Evaluation Parameters and Scores
Table 7 Competitive Intensity for BD
Table 8 Competitive Intensity for Novo Nordisk
Table 9 Competitive Intensity for Ypsomed
Table 10 Market Size, By Type, 2014–2021 (USD Million)
Table 11 Market Size, By Type, 2014–2021 (Million Units)
Table 12 Standard Pen Needles Market Size, By Region, 2014–2021 (USD Million)
Table 13 Standard Pen Needles Market Size, By Region, 2014–2021 (Million Units)
Table 14 Safety Pen Needles Market Size, By Region, 2014–2021 (USD Million)
Table 15 Standard Pen Needles Market Size, By Region, 2014–2021 (Million Units)
Table 16 Market Size, By Length, 2016–2021 (USD Million)
Table 17 4mm Pen Needles Market Size, By Region, 2014–2021 (USD Million)
Table 18 5mm Pen Needles Market Size, By Region, 2014–2021 (USD Million)
Table 19 6mm Pen Needles Market Size, By Region, 2014–2021 (USD Million)
Table 20 8mm Pen Needles Market Size, By Region, 2014–2021 (USD Million)
Table 21 10mm Pen Needles Market Size, By Region, 2014–2021 (USD Million)
Table 22 12mm Pen Needles Market Size, By Region, 2014–2021 (USD Million)
Table 23 Market Size, By Therapy, 2014–2021 (USD Million)
Table 24 Indicative List of Insulin Developments By Various Companies
Table 25 Insulin Market Size, By Region, 2014–2021 (USD Million)
Table 26 GLP-1 Market Size, By Region, 2014–2021 (USD Million)
Table 27 Growth Hormones Market Size, By Region, 2014–2021 USD Million)
Table 28 Market Size, By Mode of Purchase, 2014–2021 (USD Million)
Table 29 Market Size for Retail Purchases, By Region, 2014–2021 (USD Million)
Table 30 Indicative List of Regulatory Acts
Table 31 Market Size for Non-Retail Purchases, By Region, 2014–2021 (USD Million)
Table 32 Market Size, By Region, 2014–2021 (USD Million)
Table 33 Market Size, By Region, 2014–2021 (Million Units)
Table 34 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 35 North America: Market Size, By Type, 2014–2021 (USD Million)
Table 36 North America: Market Size, By Type, 2014–2021 (Million Units)
Table 37 North America: Market Size, By Needle Length, 2014–2021 (USD Million)
Table 38 North America: Market Size, By Therapy, 2014–2021 (USD Million)
Table 39 North America: Market Size, By Mode of Purchase, 2014–2021 (USD Million)
Table 40 Estimated Cost-Savings From the Use of Safety- Engineered Devices in the U.S.
Table 41 U.S.: Market Size, By Type, 2014–2021 (USD Million)
Table 42 U.S.: Market Size, By Type, 2014–2021 (Million Units)
Table 43 Canada: Market Size, By Type, 2014–2021 (USD Million)
Table 44 Canada: Market Size, By Type, 2014–2021 (Million Units)
Table 45 Europe: Market Size, By Country, 2014–2021 (USD Million)
Table 46 Europe: Market Size, By Country, 2014–2021 (Million Un Its)
Table 47 Europe: Market Size, By Type, 2014–2021 (USD Million)
Table 48 Europe: Market Size, By Type, 2014–2021 (Million Units)
Table 49 Europe: Market Size, By Length, 2014–2021 (USD Million)
Table 50 Europe: Market Size, By Therapy, 2014–2021 (USD Million)
Table 51 Europe: Market Size, By Mode of Purchase, 2014–2021 (USD Million)
Table 52 Estimated Annual Number of Nsi-Caused Infections in German Hospitals
Table 53 Germany: Market Size, By Type, 2014–2021 (USD Million)
Table 54 Germany: Market Size, By Type, 2014–2021 (Million Units)
Table 55 Institutions That Received Funding of More Than GBP 100,000 (USD 145,805)
Table 56 Highlights of Diabetes U.K. Activities, 2013
Table 57 U.K.: Market Size, By Type, 2014–2021 (USD Million)
Table 58 U.K.: Market Size, By Type, 2014–2021 (Million Units)
Table 59 France: Market Size, By Type, 2014–2021 (USD Million)
Table 60 France: Market Size, By Type, 2014–2021 (Million Units)
Table 61 Highlights of Awareness Campaign Conducted By Havas Pr & Idf in Italy
Table 62 Italy: Market Size, By Type, 2014–2021 (USD Million)
Table 63 Italy: Market Size, By Type, 2014–2021 (Million Units)
Table 64 Spain: Market Size, By Type, 2014–2021 (USD Million)
Table 65 Spain: Market Size, By Type, 2014–2021 (Million Units)
Table 66 European Countries With Highest Diabetic Cases and Diabetes-Related Deaths in 2015
Table 67 RoE: Market Size, By Type, 2014–2021 (USD Million)
Table 68 RoE: Market Size, By Type, 2014–2021 (Million Units)
Table 69 Asia: Market Size, By Country, 2014–2021 (USD Million)
Table 70 Asia: Market Size, By Country, 2014–2021 (Million Units)
Table 71 Asia: Market Size, By Type, 2014–2021 (USD Million)
Table 72 Asia: Market Size, By Type, 2014–2021 (Million Units)
Table 73 Asia: Market Size, By Needle Length, 2014–2021 (USD Million)
Table 74 Asia: Market Size, By Therapy, 2014–2021 (USD Million)
Table 75 Asia: Market Size, By Mode of Purchase, 2014–2021 (USD Million)
Table 76 Japan: Market Size, By Type, 2014–2021 (USD Million)
Table 77 Japan: Market Size, By Type, 2014–2021 (Million Units)
Table 78 Indicative List of Pen Needle Manufacturers in China
Table 79 China: Market Size, By Type, 2014–2021 (USD Million)
Table 80 China: Market Size, By Type, 2014–2021 (Million Units)
Table 81 India: Market Size, By Type, 2014–2021 (USD Million)
Table 82 India: Market Size, By Type, 2014–2021 (Thousand Units)
Table 83 RoA: Market Size, By Type, 2014–2021 (USD Million)
Table 84 RoA: Market Size, By Type, 2014–2021 (Thousand Units)
Table 85 RoW: Market Size, By Region, 2014–2021 (USD Million)
Table 86 RoW: Market Size, By Region, 2014–2021 (Million Units)
Table 87 RoW: Market Size, By Type, 2014–2021 (USD Million)
Table 88 RoW: Market Size, By Type, 2014–2021 (Thousand Units)
Table 89 RoW: Market Size, By Length, 2014–2021 (USD Million)
Table 90 RoW: Market Size, By Therapy, 2014–2021 (USD Million)
Table 91 RoW: Market Size, By Mode of Purchase, 2014–2021 (USD Million)
Table 92 Latin America: Market Size, By Type, 2014–2021 (USD Million)
Table 93 Latin America: Market Size, By Type, 2014–2021 (Thousand Units)
Table 94 Pen Needles Available in New Zealand
Table 95 Pacific Countries: Market Size, By Type, 2014–2021 (USD Million)
Table 96 Pacific Countries: Market Size, By Type, 2014–2021 (Thousand Units)
Table 97 Middle East & Africa: Market Size, By Type, 2014–2021 (USD Million)
Table 98 Middle East & Africa: Market Size, By Type, 2014–2021 (Thousand Units)
Table 99 Marketing and Promotion, 2014–2016
Table 100 Expansion, 2013-2015
Table 101 Product Launch, 2013-2015
Table 102 Others, 2013–2016

List of Figures (53 Figures)

Figure 1 Global Pen Needles Market Segmentation
Figure 2 Global Pen Needles Market: Research Methodology Steps
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Size Estimation Methodology: Bottom-Up Approach
Figure 5 Market Size Estimation Methodology: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Standard Pen Needles Market to Contribute to the Larger Share of the Pen Needles Market in 2016
Figure 8 8mm Pen Needles are Estimated to Command the Largest Share in 2016
Figure 9 Insulin Therapy Segment is Expected to Continue to Dominate the Pen Needles Market During the Forecast Period (2016–2021)
Figure 10 Asia is Slated to Witness the Highest Growth in the Pen Needles Market During the Forecast Period (2016–2021)
Figure 11 Asian Pen Needles Market to Register Highest Growth in the Forecast Period
Figure 12 Europe to Dominate the Global Pen Needles Market
Figure 13 Safety Pen Needles Segment to Grow at the Highest Rate
Figure 14 8mm Pen Needles Segment to Command the Highest Market Size in 2016
Figure 15 Retail Segment Expected to Command the Largest Size of the Pen Needles Market in 2021
Figure 16 Asia to Register Highest Growth Rate From 2016 to 2021
Figure 17 Pen Needles Market Segmentation
Figure 18 Pen Needles Market: Drivers, Restraints, Opportunities, & Challenges
Figure 19 Porter’s Five Forces Analysis: Pen Needles Market
Figure 20 Scoring Methodology
Figure 21 Comparison of Competitive Intensity Scores: BD, Novo Nordisk, and Ypsomed
Figure 22 Relative Positioning of Companies Based on Competitive Intensity Scores and Pen Needle Focus
Figure 23 Safety Pen Needles By BD and Standard Pen Needles By Novo Nordisk are Premium-Priced
Figure 24 BD has A Robust Portfolio of Both Standard and Safety Pen Needles
Figure 25 BD has More Focus on Innovation in Its Pen Needles Business
Figure 26 BD has the Highest Production Capacity of Pen Needles
Figure 27 BD and Novo Nordisk Have A Strong Geographic Presence
Figure 28 BD and Novo Nordisk Showcase High Focus on Marketing and Promotional Activities
Figure 29 Novo Nordisk has High Focus on Diabetes Education and Awareness
Figure 30 Novo Nordisk Aggressively Follows the Growth Strategy of Partnerships and Agreements
Figure 31 Novo Nordisk is the Most Experienced Firm in Pen Needles Market
Figure 32 BD, Novo Nordisk, and Ypsomed Equally Exhibit High Compliance With Industry Standards
Figure 33 Indicative List of Key Players (Manufacturers/Marketers) in the Global Pen Needles Market
Figure 34 Indicative List of Players (Manufacturers/Marketers) in Pen Needles Market in Specific Countries
Figure 35 Standard Pen Needles Segment to Command the Largest Market Size in 2016
Figure 36 Availability of Pen Needles, By Company
Figure 37 8mm Pen Needles Segment to Command the Largest Market Size in 2016 and 2021
Figure 38 Insulin Therapy Segment to Command the Largest Size of Pen Needles Market in 2016
Figure 39 Retail Purchases Segment to Command the Largest Market Share in 2016
Figure 40 Europe to Command the Largest Share of the Global Pen Needles Market in 2016
Figure 41 U.S. to Witness Highest Growth in the North American Pen Needles Market From 2016 to 2020
Figure 42 European Pen Needles Market Snapshot
Figure 43 Diabetes U.K.: Funds Raised vs Funds Invested
Figure 44 China to Witness Highest Growth in the Asian Pen Needles Market From 2016 to 2021
Figure 45 Market Share Analysis, By Key Player, 2015
Figure 46 Growth Strategies, By Company
Figure 47 Companies Adopted Marketing & Promotion as the Key Growth Strategy From 2013-2016
Figure 48 Geographic Revenue Mix of Top Market Players
Figure 49 Becton, Dickinson & Company: Company Snapshot
Figure 50 Novo Nordisk A/S: Company Snapshot
Figure 51 Ypsomed Holding AG: Company Snapshot
Figure 52 B. Braun Melsungen: Company Snapshot
Figure 53 Terumo Corporation: Company Snapshot

The pen needles market is expected to reach USD 2.81 Billion by 2021 from USD 1.65 Billion in 2016, growing at a CAGR of 11.2% from 2016 to 2021.

The market is segmented on the basis of type, needle length, therapy, and mode of purchase. By type, the market is categorized into standard and safety pen needles. The standard pen needles segment is expected to account for the largest share of the market in 2016. The large share of this segment can be attributed to the low cost of these instruments and increasing adoption in emerging nations. However, the safety pen needles segment is projected to grow at the highest CAGR during the forecast period.

The pen needles market, based on needle length, is segmented into 4mm, 5mm, 6mm, 8mm, 10mm, and 12mm. The 8mm needle length segment is expected to account for the largest share of the market in 2016. However, pen needles with 4mm length are expected to grow at the highest CAGR in the market, by needle length. Growth in this segment can be attributed to the increasing adoption of pen needles of shorter length and technological advancements in 4mm pen needles.

On the basis of therapy, the pen needles market is segmented into insulin therapy, glucagon-like-peptide-1 (GLP-1) therapy, and growth hormone therapy. The insulin therapy segment is expected to account for the largest share of the market in 2016, and is projected to grow at the highest CAGR during the forecast period. Factors responsible for the growth of insulin therapy during the forecast period include increasing diabetes population, favorable reimbursement scenario and strong government support in selected countries, and awareness campaigns and conferences to improve diabetes care and adoption of pen needles.

Based on mode of purchase, the pen needles market is segmented into retail and non-retail modes of purchase. The retail mode of purchase segment is expected to account for the largest share of the market, and is projected to grow at the highest CAGR during the forecast period. The large share of the retail mode of purchase segment can be attributed to availability of discounts at retail outlets and pharmacies; availability of free samples; and increasing ease of purchase through mail ordering and online ordering of pen needles.

On the basis of regions, the pen needles market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Europe is expected to account for the largest share of the market in 2016. The large share of Europe can be attributed to the EU’s directive on prevention of sharp injuries in hospitals and the healthcare sector; changes in the regulatory framework in Germany to minimize needlestick injuries; high incidence of diabetes across European nations; activities undertaken in the U.K. to pool funds for diabetes care and research; higher insurance coverage and increase in aging population and affordability in France; awareness campaigns for diabetes in Italy; and the high export potential of injectable drug delivery devices in Spain. However, the Asian region is expected to grow at the highest CAGR during the forecast period.

Source: International Diabetes Federation (IDF), National Diabetes Services Scheme (NDSS), Parenteral Drug Association (PDA), Food and Drug Administration (FDA), WHO, American Diabetes Association, American Association of Diabetes Educators (AADE), CDC, European Association for the Study of Diabetes (EASD), Asian Association for the Study of Diabetes (AASD), Expert Interviews, and MarketsandMarkets Analysis

The major players in the global pen needles market include Becton, Dickinson and Company (U.S.), Novo Nordisk (Denmark), Ypsomed Holding AG (Switzerland), B. Braun Melsungen AG (Germany), HTL-Strefa S.A. (Poland), Terumo Corporation (Japan), Artsana S.p.a (Italy), Owen Mumford Ltd (U.K.), Allison Medical, Inc. (U.S.), and Ultimed, Inc. (U.S.).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst